A European panel of experts has highlighted the life-cycle assessment framework developed by Dr. Regier, Associate Director of the ATM, as the way forward to address timely evidence-informed access to precision oncology products.
During the recent Health Technology Assessment international (HTAi) Annual Meeting, taking place in Seville, Spain in June 2024, there was a noteworthy Bayer Oncology symposium titled “Precision Oncology: Unlocking Access to Breakthrough Therapies for Patients with Cancer”. In the session, Professor Yvonne-Beatrice Böhler of Technische Hochschule Köln, Germany, presented Dr. Regier’s framework from the article “Perspective on Life-Cycle Health Technology Assessment and Real-World Evidence for Precision Oncology in Canada” originally published in npj Precision Oncology in 2022.
Dr. Dean Regier
Dr. Böhler highlighted the need for evolving health technology assessment frameworks that go beyond traditional evidence generation in clinical trials, emphasizing the growing importance of real-world shaping precision oncology strategies that will make healthcare systems more equitable and efficient. Dr. Dean Regier authored this article in 2022 with colleagues Dr. Samantha Pollard, Melanie McPhail, Dr. Tania Bubela, Dr. Timothy Hanna, Dr. Cheryl Ho, Dr. Howard Lim, Dr. Kelvin Chan, Dr. Stuart Peacock & Deirdre Weymann.
The Academy of Translational Medicine (ATM) is rooted in its mission to becoming a fully integrated powerhouse for advancing translational medicine on a worldwide scale. Seeing the Canadian-based article by Dr. Regier and colleagues used by Dr. Böhler as a prime example of how international health systems should be thinking about real-world evidence and life-cycle evaluation, illustrates the wide-reaching impacts of ATM-supported research. External stakeholders sharing this Canadian-based work as a thought-provoking strategy for international audiences is an indication of its applicability and relevance on a global level. The ATM congratulates the authors and encourages its community to learn more about the article.
The Symposium recording is available here, and is posted below (1:02 mark).
The full article by Dr. Regier in Precision Oncology can be found here.